Skip to content

Conventures

Active
Private limited companyfounded 2024active for 1 yearDrie Lindenstraat 14, 1831 Machelen (Brab.), BelgiumKBO/BCE: BE 1017.838.420
Summary

Conventures has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €246,326 and a net result of -€3,674. Its solvency ranks better than 95% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Financials · financial year 2025, micro format

Source amounts without an identifiable currency are assumed to be EUR.

Equity
€246,326
Total assets
€246,326
Net result
-€3,674
Working capital
Not included in this filing

Turnover and EBIT margin not published: the micro format does not require them.

Key figures and ratios
2025 value
Solvency
100.0%
ROE
-1.5%
ROA
-1.5%

Peer companies

Historical observation

Of the 277 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 96.8% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a small loss
0.7% went bankrupt
2.5% stopped otherwise
96.8% still going

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 277 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 16 lines
Balance sheet Code2025
Assets
Total assets20/58€246,326
Current assets29/58€246,326
Amounts receivable within one year40/41€761
Other amounts receivable41€761
Current investments50/53€41,000
Cash at bank and in hand54/58€204,565
Equity and liabilities
Total equity and liabilities10/49€246,326
Equity10/15€246,326
Contributions10/11€250,000
Profit (loss) carried forward14-€3,674
Income statement Code2025
Gross operating margin9900-€3,674
Operating profit (loss)9901-€3,674
Profit (loss) for the period before taxes9903-€3,674
Profit (loss) for the period9904-€3,674
Profit (loss) for the period to be appropriated9905-€3,674
Appropriation of the result
Profit (loss) to be appropriated9906-€3,674

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Gross operating margin9900-€3,674
Operating profit (loss)9901-€3,674
Profit (loss) for the period before taxes9903-€3,674
Profit (loss) for the period9904-€3,674
Profit (loss) for the period to be appropriated9905-€3,674
Line2025
Assets
Total assets20/58€246,326
Current assets29/58€246,326
Amounts receivable within one year40/41€761
Other amounts receivable41€761
Current investments50/53€41,000
Cash at bank and in hand54/58€204,565
Equity and liabilities
Total equity and liabilities10/49€246,326
Equity10/15€246,326
Contributions10/11€250,000
Profit (loss) carried forward14-€3,674
Line2025
Profit (loss) for the period9904-€3,674
Operating cash flow (approximation)-€3,674

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
30-06-2025 micro format 30-01-2026 2026-00021478

Similar companies · same sector, comparable size

Of the 760 active companies whose main activity is research and development on biotechnology (NACE 72101), figures are known for 484. 325 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.